Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $74.6M | $97.9M | $34.2M | $991.5K | $770K | |
| Revenue Growth (YoY) | 34579.9% | 31.3% | -65.04% | -97.1% | -22.33% | |
| Cost of Revenues | $16.6M | $11.9M | $6.8M | $5.4M | $2.4M | |
| Gross Profit | $58M | $86M | $27.5M | -$4.4M | -$1.6M | |
| Gross Profit Margin | 77.75% | 87.83% | 80.23% | -446.18% | -208.61% | |
| R&D Expenses | $3.2M | $15M | $17.4M | $23M | $21M | |
| Selling, General & Admin | $12.9M | $24.9M | $21.6M | $21.1M | $20.6M | |
| Other Inc / (Exp) | $778.2K | -$474.8K | -$8M | $3.4M | $1.4M | |
| Operating Expenses | $16.3M | $39.8M | $39M | $44.1M | $41.6M | |
| Operating Income | $41.7M | $46.2M | -$11.6M | -$48.5M | -$43.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $42.6M | $45.6M | -$18.8M | -$38.1M | -$37.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $90.5K | $9M | -$4.6M | -$2.8M | $57.4K | |
| Net Income to Company | $42.5M | $36.7M | -$14.2M | -$35.3M | -$37.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $42.5M | $36.7M | -$14.2M | -$35.3M | -$37.6M | |
| Basic EPS (Cont. Ops) | $1.59 | $1.27 | -$0.45 | -$1.20 | -$1.24 | |
| Diluted EPS (Cont. Ops) | $1.52 | $1.23 | -$0.45 | -$1.20 | -$1.24 | |
| Weighted Average Basic Share | $26.7M | $28.9M | $31.5M | $29.3M | $30.3M | |
| Weighted Average Diluted Share | $28M | $29.9M | $31.5M | $29.3M | $30.3M | |
| EBITDA | $41.8M | $46.6M | -$10.3M | -$47.3M | -$41.8M | |
| EBIT | $41.7M | $46.2M | -$11.6M | -$48.5M | -$43.2M | |
| Revenue (Reported) | $74.6M | $97.9M | $34.2M | $991.5K | $770K | |
| Operating Income (Reported) | $41.7M | $46.2M | -$11.6M | -$48.5M | -$43.2M | |
| Operating Income (Adjusted) | $41.7M | $46.2M | -$11.6M | -$48.5M | -$43.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $30.1M | $5.1M | $2.5M | $206.9K | $145.4K | |
| Revenue Growth (YoY) | 37.96% | -83.08% | -51.77% | -91.58% | -29.73% | |
| Cost of Revenues | $3.4M | $1.1M | $552.1K | $648.6K | $293.7K | |
| Gross Profit | $26.7M | $4M | $1.9M | -$441.8K | -$148.3K | |
| Gross Profit Margin | 88.69% | 78.79% | 77.53% | -213.53% | -102% | |
| R&D Expenses | $5.9M | $5M | $5.8M | $4.9M | $4.5M | |
| Selling, General & Admin | $7.2M | $5.5M | $5.1M | $5.3M | $2.4M | |
| Other Inc / (Exp) | -$64.9K | $2.8M | $517.3K | $297.3K | -- | |
| Operating Expenses | $13.1M | $10.5M | $10.8M | $10.2M | $6.9M | |
| Operating Income | $13.6M | -$6.5M | -$8.9M | -$10.7M | -$7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $13.6M | -$3.5M | -$8.1M | -$9.7M | -$7.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.1M | -$2.1M | -$2.1M | $22.2K | -$1.2M | |
| Net Income to Company | $11.5M | -$1.4M | -$6M | -$9.7M | -$5.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $11.5M | -$1.4M | -$6M | -$9.7M | -$5.9M | |
| Basic EPS (Cont. Ops) | $0.40 | -$0.04 | -$0.20 | -$0.32 | -$0.16 | |
| Diluted EPS (Cont. Ops) | $0.38 | -$0.04 | -$0.20 | -$0.32 | -$0.16 | |
| Weighted Average Basic Share | $28.9M | $31.3M | $29.4M | $30.5M | $37.9M | |
| Weighted Average Diluted Share | $30M | $31.3M | $29.4M | $30.5M | $37.9M | |
| EBITDA | $13.7M | -$6.2M | -$8.6M | -$10.3M | -$6.7M | |
| EBIT | $13.6M | -$6.5M | -$8.9M | -$10.7M | -$7M | |
| Revenue (Reported) | $30.1M | $5.1M | $2.5M | $206.9K | $145.4K | |
| Operating Income (Reported) | $13.6M | -$6.5M | -$8.9M | -$10.7M | -$7M | |
| Operating Income (Adjusted) | $13.6M | -$6.5M | -$8.9M | -$10.7M | -$7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $104.6M | $53.2M | $4.7M | $4.2M | $507.9K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $13.7M | $8.5M | $2.9M | $5M | $1.5M | |
| Gross Profit | $90.9M | $44.7M | $1.7M | -$869K | -$1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $13.9M | $14.9M | $21.5M | $22.4M | $18.8M | |
| Selling, General & Admin | $25.3M | $20.3M | $21.8M | $19.9M | $15.7M | |
| Other Inc / (Exp) | -$639.4K | $6.6M | -$11.7M | $1.2M | -- | |
| Operating Expenses | $39.2M | $35.1M | $43.3M | $42.3M | $34.5M | |
| Operating Income | $51.8M | $9.6M | -$41.6M | -$43.1M | -$35.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $51.2M | $16.4M | -$52.3M | -$37.4M | -$33.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $9.2M | $1.3M | -$9.8M | $3.9M | -$1.2M | |
| Net Income to Company | $42M | $15.2M | -$42.6M | -$41.3M | -$32.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $42M | $15.2M | -$42.6M | -$41.3M | -$32.2M | |
| Basic EPS (Cont. Ops) | $1.46 | $0.48 | -$1.42 | -$1.35 | -$0.96 | |
| Diluted EPS (Cont. Ops) | $1.40 | $0.46 | -$1.42 | -$1.35 | -$0.96 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $52.1M | $10.7M | -$40.4M | -$41.8M | -$34.3M | |
| EBIT | $51.8M | $9.6M | -$41.6M | -$43.1M | -$35.5M | |
| Revenue (Reported) | $104.6M | $53.2M | $4.7M | $4.2M | $507.9K | |
| Operating Income (Reported) | $51.8M | $9.6M | -$41.6M | -$43.1M | -$35.5M | |
| Operating Income (Adjusted) | $51.8M | $9.6M | -$41.6M | -$43.1M | -$35.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $77.5M | $32.8M | $3.3M | $620.7K | $358.6K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $9.2M | $5.9M | $2.1M | $1.8M | $919.2K | |
| Gross Profit | $68.3M | $26.9M | $1.1M | -$1.1M | -$560.7K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $12.8M | $12.7M | $16.8M | $16.2M | $14M | |
| Selling, General & Admin | $19.6M | $15M | $15.2M | $14M | $9M | |
| Other Inc / (Exp) | -$401.3K | $6.7M | $2.9M | $663.8K | $1M | |
| Operating Expenses | $32.5M | $27.7M | $32M | $30.2M | $23.1M | |
| Operating Income | $35.8M | -$858.4K | -$30.9M | -$31.3M | -$23.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $35.4M | $6.2M | -$27.3M | -$26.5M | -$22.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.2M | -$1.5M | -$6.6M | $65.6K | -$1.1M | |
| Net Income to Company | $29.2M | $7.7M | -$20.7M | -$26.6M | -$21.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $29.2M | $7.7M | -$20.7M | -$26.6M | -$21.2M | |
| Basic EPS (Cont. Ops) | $1.02 | $0.22 | -$0.71 | -$0.88 | -$0.62 | |
| Diluted EPS (Cont. Ops) | $0.97 | $0.21 | -$0.71 | -$0.88 | -$0.62 | |
| Weighted Average Basic Share | $86.4M | $97.7M | $87.9M | $90.5M | $103M | |
| Weighted Average Diluted Share | $89.7M | $98.5M | $87.9M | $90.5M | $103M | |
| EBITDA | $36M | $142.8K | -$29.9M | -$30.3M | -$22.8M | |
| EBIT | $35.8M | -$858.4K | -$30.9M | -$31.3M | -$23.6M | |
| Revenue (Reported) | $77.5M | $32.8M | $3.3M | $620.7K | $358.6K | |
| Operating Income (Reported) | $35.8M | -$858.4K | -$30.9M | -$31.3M | -$23.6M | |
| Operating Income (Adjusted) | $35.8M | -$858.4K | -$30.9M | -$31.3M | -$23.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $43M | $89.9M | $81.3M | $58.5M | $29.7M | |
| Short Term Investments | $4.3M | $1.3M | $58.3M | $43.6M | $26.8M | |
| Accounts Receivable, Net | $12.1M | $20.9M | $3.5M | $303.9K | $132.6K | |
| Inventory | $8M | $2M | $5.3M | $1.7M | $1.1M | |
| Prepaid Expenses | -- | $2.3M | $761.2K | -- | -- | |
| Other Current Assets | $369K | $2.3M | $761.2K | $1.6M | $1.3M | |
| Total Current Assets | $67.8M | $115.1M | $92.7M | $62.1M | $32.3M | |
| Property Plant And Equipment | $949.6K | $1.9M | $2.9M | $6M | $4.9M | |
| Long-Term Investments | $1.9M | $1.1M | $672.7K | $773.4K | $731.1K | |
| Goodwill | -- | $14.7M | -- | -- | -- | |
| Other Intangibles | -- | $27.2M | $26.8M | $26.4M | $26.1M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $71.2M | $160.6M | $128.2M | $103.6M | $71.2M | |
| Accounts Payable | $598.3K | $607.5K | $952.3K | $1.5M | $3.3M | |
| Accrued Expenses | $2.9M | $3.9M | $934.5K | $2.2M | $2.6M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $297.2K | $838.4K | $915.6K | |
| Other Current Liabilities | -- | $5.8M | $1.7M | $891.7K | $502.8K | |
| Total Current Liabilities | $4.1M | $12.6M | $3.9M | $5.7M | $7.3M | |
| Long-Term Debt | -- | -- | $50.7K | $2.2M | $1.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.5M | $26.1M | $13.7M | $17.6M | $16.9M | |
| Common Stock | $28.6K | $33.8K | $34.8K | $36.1K | $37.9K | |
| Other Common Equity Adj | -- | -- | $293.1K | $146.7K | $418.4K | |
| Common Equity | $66.7M | $134.5M | $114.5M | $86M | $54.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $66.7M | $134.5M | $114.5M | $86M | $54.3M | |
| Total Liabilities and Equity | $71.2M | $160.6M | $128.2M | $103.6M | $71.2M | |
| Cash and Short Terms | $47.3M | $89.9M | $81.3M | $58.5M | $29.7M | |
| Total Debt | -- | -- | $50.7K | $2.2M | $1.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $83.9M | $86.5M | $63.4M | $37.7M | $11.4M | |
| Short Term Investments | $1.3M | $5M | $53.2M | $26.9M | -- | |
| Accounts Receivable, Net | $14.6M | $8M | $825.5K | $178.2K | $55.9K | |
| Inventory | $3.3M | $5.4M | $4.5M | $1.3M | $1.1M | |
| Prepaid Expenses | $485.1K | $1.2M | $1.3M | -- | -- | |
| Other Current Assets | $485.1K | $1.2M | $1.3M | $996.7K | -- | |
| Total Current Assets | $102.3M | $101.9M | $71.3M | $40.1M | $14.1M | |
| Property Plant And Equipment | $1.5M | $2.9M | $5.8M | $5.3M | $3.9M | |
| Long-Term Investments | $1M | $767.5K | $778.9K | $784.4K | $659.9K | |
| Goodwill | -- | $15.4M | -- | -- | -- | |
| Other Intangibles | -- | $26.9M | $26.5M | $26.2M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $105.4M | $147.8M | $108.7M | $72.4M | $44.7M | |
| Accounts Payable | $800K | $2.1M | $1.4M | $2.2M | $1.5M | |
| Accrued Expenses | $2.1M | $1.5M | $1.8M | $1.8M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $292.5K | $794.5K | $896.8K | -- | |
| Other Current Liabilities | -- | $2.2M | $710.7K | $838K | -- | |
| Total Current Liabilities | $4.1M | $6M | $5.1M | $5.8M | $3.7M | |
| Long-Term Debt | -- | $126.3K | $2.3M | $1.5M | $727.9K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.2M | $12.9M | $9.2M | $8.6M | $4.9M | |
| Common Stock | $28.9K | $34.3K | $35.4K | $36.8K | $53K | |
| Other Common Equity Adj | -- | -- | $612.7K | $408.4K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $100.2M | $134.9M | $99.5M | $63.8M | $39.8M | |
| Total Liabilities and Equity | $105.4M | $147.8M | $108.7M | $72.4M | $44.7M | |
| Cash and Short Terms | $83.9M | $86.5M | $63.4M | $37.7M | $11.4M | |
| Total Debt | -- | $126.3K | $2.3M | $1.5M | $727.9K | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $42.5M | $36.7M | -$14.2M | -$35.3M | -$37.6M | |
| Depreciation & Amoritzation | $138.6K | $335.4K | $1.3M | $1.2M | $1.4M | |
| Stock-Based Compensation | $2.7M | $5.5M | $7.5M | $8.3M | $5.4M | |
| Change in Accounts Receivable | -$13M | -$8.7M | $15M | $2.5M | $186.4K | |
| Change in Inventories | -$7.9M | $5.7M | -$3.5M | $413.1K | $265.5K | |
| Cash From Operations | $28.2M | $41.1M | $6.6M | -$22.1M | -$29.2M | |
| Capital Expenditures | $774.4K | $669.5K | $1.4M | $1.4M | $748.4K | |
| Cash Acquisitions | -$714.5K | -$1.2M | -- | -- | -- | |
| Cash From Investing | -$5.8M | $4.1M | -$58.2M | $15.4M | $17.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | $14.2M | $1.4M | -- | |
| Other Financing Activities | -$1.5M | -- | -- | -- | -- | |
| Cash From Financing | $19.7M | $450.4K | -$14M | -$1.4M | $103.9K | |
| Beginning Cash (CF) | $893.1K | $88.6M | $23M | $14.9M | $2.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $42.1M | $45.6M | -$65.6M | -$8.1M | -$12M | |
| Ending Cash (CF) | $43M | $134.2M | -$42.7M | $6.9M | -$9M | |
| Levered Free Cash Flow | $27.4M | $40.4M | $5.1M | -$23.4M | -$29.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $11.5M | -$1.4M | -$6M | -$9.7M | -$5.9M | |
| Depreciation & Amoritzation | $94K | $316.4K | $270.3K | $351.2K | $267.4K | |
| Stock-Based Compensation | $1.4M | $2.2M | $2.2M | $1M | $500.6K | |
| Change in Accounts Receivable | -$1.8M | $4M | $278.7K | $324.1K | $164.2K | |
| Change in Inventories | $557.6K | -$735.8K | $170.6K | $117.4K | $38.4K | |
| Cash From Operations | $11.5M | $1.1M | -$6.6M | -$7.2M | -$5.9M | |
| Capital Expenditures | $165.7K | $230K | $236.6K | $174.4K | $75.1K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $869.8K | $4.7M | $3.2M | $4.2M | $2.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $10.4M | $166.3K | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $5.5K | -$10.4M | -$166.3K | -- | $4.1M | |
| Beginning Cash (CF) | $82.7M | $81.5M | $10.2M | $10.8M | $11.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $12.4M | -$4.5M | -$3.6M | -$3.1M | $328.8K | |
| Ending Cash (CF) | $95M | $77M | $6.6M | $7.7M | $11.8M | |
| Levered Free Cash Flow | $11.3M | $888.3K | -$6.8M | -$7.4M | -$6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $42M | $15.2M | -$42.6M | -$41.3M | -$32.2M | |
| Depreciation & Amoritzation | $289.9K | $1.1M | $1.2M | $1.3M | $1.2M | |
| Stock-Based Compensation | $4.4M | $6.8M | $8.9M | $5.9M | $3.3M | |
| Change in Accounts Receivable | -$5.1M | $6.4M | $4.7M | $334K | $168K | |
| Change in Inventories | $7.2M | -$2.4M | $922K | -$143.8K | $153.5K | |
| Cash From Operations | $56.2M | $15.5M | -$21.3M | -$25.7M | -$31.2M | |
| Capital Expenditures | $1M | $1.3M | $1.2M | $1.1M | $641.1K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $4.3M | -$3.8M | -$47.5M | $26.4M | $26.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $13M | $2.4M | $159.7K | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $993K | -$12.8M | -$2.4M | -$159.7K | $4.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $61.4M | -$1.2M | -$71.3M | $557.7K | $646.3K | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $55.1M | $14.2M | -$22.5M | -$26.8M | -$31.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $29.2M | $7.7M | -$20.7M | -$26.6M | -$21.2M | |
| Depreciation & Amoritzation | $232.7K | $1M | $917.6K | $1M | $839.2K | |
| Stock-Based Compensation | $3.9M | $5.1M | $6.5M | $4.1M | $2M | |
| Change in Accounts Receivable | -$2.6M | $12.5M | $2.3M | $117.4K | $99K | |
| Change in Inventories | $4.4M | -$3.7M | $790.7K | $233.7K | $121.8K | |
| Cash From Operations | $36.2M | $10.6M | -$17.3M | -$20.9M | -$22.9M | |
| Capital Expenditures | $547.7K | $1.1M | $900.7K | $675.3K | $568.1K | |
| Cash Acquisitions | $314.6K | -- | -- | -- | -- | |
| Cash From Investing | $3M | -$4.9M | $5.8M | $16.8M | $26.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $13M | $1.2M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $450.4K | -$12.8M | -$1.2M | -- | $4.8M | |
| Beginning Cash (CF) | $183.4M | $265M | $30.4M | $47.8M | $24.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $39.7M | -$7.1M | -$12.7M | -$4.1M | $8.5M | |
| Ending Cash (CF) | $223.1M | $257.9M | $17.7M | $43.6M | $33M | |
| Levered Free Cash Flow | $35.7M | $9.4M | -$18.2M | -$21.6M | -$23.5M | |
Signup to receive the latest stock alerts
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
With the market starting to look skittish on pure-play AI…
Market Cap: $4.4T
P/E Ratio: 62x
Market Cap: $4.1T
P/E Ratio: 37x
Market Cap: $3.9T
P/E Ratio: 40x
SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.
Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.
Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.